The Current Ratio as of November 2024 (TTM) for Aptinyx Inc. (APTX) is 5.12

According to Aptinyx Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.12. This represents a change of -65.25% compared to the average of 14.74 of the last 4 quarters.

Aptinyx Inc. (APTX) Historical Current Ratio (quarterly & annually)

How has APTX Current Ratio performed in the past?

The mean historical Current Ratio of Aptinyx Inc. over the last ten years is 19.44. The current 5.12 Current Ratio has changed 2.54% with respect to the historical average. Over the past ten years (40 quarters), APTX's Current Ratio was at its highest in in the June 2021 quarter at 39.56. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Aptinyx Inc. (APTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aptinyx Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptinyx Inc. (APTX) Average Current Ratio

How has APTX Current Ratio performed in the past?

The current Current Ratio of Aptinyx Inc. (APTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptinyx Inc. (APTX) Current Ratio vs. Peers

How is APTX’s Current Ratio compared to its peers?

Aptinyx Inc.’s Current Ratio is greater than Evelo Biosciences, Inc. (0.48), less than Magenta Therapeutics, Inc. (14.64), greater than Aileron Therapeutics, Inc. (4.69), greater than ABVC BioPharma, Inc. (0.33), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.00), greater than Assembly Biosciences, Inc. (2.74), less than Instil Bio, Inc. (15.06), less than Nuvation Bio Inc. (11.49), greater than Allarity Therapeutics, Inc. (2.01), greater than NeuroBo Pharmaceuticals, Inc. (2.94), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than Spero Therapeutics, Inc. (2.68), less than Achilles Therapeutics plc (8.24), less than Adial Pharmaceuticals, Inc. (5.69), greater than TransCode Therapeutics, Inc. (1.25), greater than Aditxt, Inc. (0.07), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Avenue Therapeutics, Inc. (4.30),

Build a custom stock screener for Aptinyx Inc. (APTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptinyx Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptinyx Inc. (APTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptinyx Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.